VP, U.S. Medical Affairs
Core
Senior U.S. medical leader responsible for end-to-end launch readiness, execution, and early commercialization success for Dyne's first approved product in the neuromuscular disease space.
Role type
VP, U.S. Medical Affairs (Commercial Launch & Strategy)
Builds
U.S. Medical Affairs organization and launch execution for first-in-class rare disease therapeutics
Domain
Biotechnology / Rare Diseases (Neuromuscular)
Deliverable
product features
Required skills
U.S. medical strategy definition, launch readiness management, KOL engagement, payer and patient community strategy, scientific data translation, organizational scaling, cross-functional leadership
Preferred skills
Experience transitioning clinical-stage to commercial-stage, first-launch environment expertise, rare disease portfolio management
Technologies
None stated
Responsibilities
Deliver a highly effective U.S. medical launch enabling evidence-based adoption; Establish a credible scientific presence with U.S. KOLs, payers, and patient communities; Build a scalable, high-performing Medical Affairs organization; Translate scientific and clinical data into strategies for access and lifecycle value; Establish foundational capabilities in a first-launch environment; Own U.S. medical strategy, launch readiness, and execution
Seniority
VP, Executive Leadership